The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients

Thrombosis Research

Volumn 130, Issue 1, 2012, Pages 110-114

  Lawrie, A S ^a   Hills, J ^b   Longair, I ^b   Green, L ^a   Gardiner, C ^b   MacHin, S J ^a,b   Cohen, H ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

INR; over anticoagulation; Point of care; Prothrombin time; warfarin

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; RECOMBINANT THROMBOPLASTIN; THROMBIN; THROMBOPLASTIN; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; PROTHROMBIN TIME;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME; RABBITS; THROMBIN; WARFARIN; YOUNG ADULT;

EID: 84861838199     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.08.027     Document Type: Article

References (26)

1. C. Gardiner, I. Longair, M.A. Pescott, H. Erwin, J. Hills, and S.J. Machin Self-monitoring of oral anticoagulation: does it work outside trial conditions? J Clin Pathol 62 2009 168 171
2. C. Gardiner, K. Williams, I.J. Mackie, S.J. Machin, and H. Cohen Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring Br J Haematol 128 2005 242 247
3. WHO Expert Committee on Biological Standardization Requirements for thromboplastins and plasma used to control oral anticoagulation therapy Thirty-third Report Technical Report Series 687 1983 WHO Geneva 81 105
4. T.B. Kirkwood Calibration of reference thromboplastins and standardisation of the prothrombin time ratio Thromb Haemost 49 1983 238 244
5. S. Panneerselvam, C. Baglin, W. Lefort, and T. Baglin Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin Br J Haematol 103 1998 422 424
6. G. Palareti, N. Leali, S. Coccheri, M. Poggi, C. Manotti, and A. D'Angelo Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy Lancet 348 1996 423 428
7. T.P. Baglin, D.M. Keeling, and H.G. Watson Guidelines on oral anticoagulation (warfarin): third edition-2005 update Br J Haematol 132 2006 277 285
8. M. Makris, J.J. van Veen, and R. Maclean Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient J Thromb Thrombolysis 29 2010 171 181
9. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
10. J. Horsti, H. Uppa, and J.A. Vilpo Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents Clin Chem 51 2005 553 560
11. S. Testa, G. Morstabilini, A. Fattorini, L. Galli, N. Denti, and A. D'Angelo Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system Haematologica 87 2002 1265 1273
12. W. Plesch, and A.M. van den Besselaar Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy Int J Lab Hematol 31 2009 20 25
13. W. Plesch, T. Wolf, N. Breitenbeck, L.D. Dikkeschei, A. Cervero, and P.L. Perez Results of the performance verification of the CoaguChek XS system Thromb Res 123 2008 381 389
14. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
15. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
16. J.M. Bland, and D.G. Altman Comparing methods of measurement: why plotting difference against standard method is misleading Lancet 346 1995 1085 1087
17. P. Han, K.P. Fung, and U. Rahdakrishnan Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinised plasma Thromb Haemost 65 1991 360 363
18. R. Biggs Report on the standardisation of the one-stage prothrombin time for the control of anticoagulant therapy Thromb Diath Haemorrh Suppl 17 1965 303 331
19. L. Poller Standardization of anticoagulant treatment: the Manchester regional thromboplastin scheme Br Med J 2 1964 565 566
20. A.M. van den Besselaar, V. Chantarangkul, and A. Tripodi Thromboplastin standards Biologicals 38 2010 430 436
21. T. Baglin Avoiding overanticoagulation: pharmacogenomics or pragmatism? Thromb Haemost 85 2001 945 946
22. T. Baglin Management of warfarin (coumarin) overdose Blood Rev 12 1998 91 98
23. C. Watala, J. Golanski, and P. Kardas Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients Thromb J 1 2003 7
24. S.E. Lind, P.W. Callas, E.A. Golden, K.A. Joyner Jr., and T.L. Ortel Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy Blood Coagul Fibrinolysis 8 1997 48 53
25. A. Gatt, J.J. van Veen, A.M. Woolley, S. Kitchen, P. Cooper, and M. Makris Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro Thromb Haemost 100 2008 350 355
26. A. Gatt, J.J. van Veen, A. Bowyer, A.M. Woolley, P. Cooper, and S. Kitchen Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation Br J Haematol 142 2008 946 952